📰 Product Testing News
Page 59 - Product Testing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Product Testing. Real-time updates on events, politics, business and more.
January 12, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Addex Successfully Completes $11.5 Million Capital Increase Including Full Exercise of ... Addex TherapeuticsJanuary 11, 2021 GMT Geneva, Switzerland, January 11, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today the successful completion of the previously announce...
January 12, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Victory Square Technologies Portfolio Company Receives Brazilian ANVISA Approval for Sale, ... Victory Square Technologies Inc.January 11, 2021 GMT Victory Square Health received Brazilian ANVISA approval for Safetest 15 Minute Covid-19 Rapid Test for distribution, sale, and usage in Brazil The Safetest 15 Minute Covid-19 Rapid Test has a 96.6% Sensitivity, and can confirm whether one is currently in...
January 12, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Cannabix Technologies Granted U.S. Patent - Cannabis Drug Detection Device Cannabix Technologies Inc.January 12, 2021 GMT VANCOUVER, British Columbia, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, announces that the United States P...
January 12, 2021
Press release content from Accesswire. The AP news staff was not involved in its creation. MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab January 12, 2021 GMT PLANEGG/MUNICH, GERMANY and MONTREAL, QC / ACCESSWIRE / January 12, 2021 / MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:MOR) and Incyte (NASDAQ:INCY) today announced that Health Canada has accepted the New Drug Submission (NDS) for tafasitamab, an anti-CD19 anti...
January 12, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation. TTC Oncology to Present at Biotech Showcase™ Digital 2021 January 12, 2021 GMT CHICAGO--(BUSINESS WIRE)--Jan 12, 2021-- TTC Oncology (“TTC” or the “Company”) CEO and CMO Arek Dudek, MD, PhD, will be participating in the Biotech Showcase virtual conference occurring January 11-15, 2021. Dr. Dudek will be providing a Company overview and update on the Company’s financing needs as well as TTC�...
January 11, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
January 11, 2021
Turn on desktop notifications for breaking stories about interest? OffOn Indonesia green-lights emergency use of Chinese vaccine Indonesias Food and Drug Authority has authorized emergency use of the COVID-19 vaccine produced by China-based Sinovac Biotech Ltd By VICTORIA MILKO and EDNA TARIGAN Associated Press January 11, 2021, 9:24 AM • 3 min read Catch up on the developing stories making headlines.The Associated Press JAKARTA, Indonesia -- Indonesia’s Food and Drug Authority on Monday g...
January 11, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.
January 11, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
January 11, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 ... Aadi Bioscience Inc.January 11, 2021 GMT Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater China EOC Pharma acquires exclusive development and commercialization rights to ABI-009 in Greater China Aadi will receive an upfront payment, regulatory and sal...